Clinical Trial Update: Study of Pomalidomide in Anal Cancer Precursors [Phase 2]

View source ↗

Summary

Phase 2 study investigating pomalidomide in high-grade squamous intraepithelial lesion (HSIL) precursors; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Squamous Intraepithelial Lesion

Drugs mentioned

• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Kirby Institute | Conditions: High Grade Squamous Intra-epithelial Lesion (HSIL) | Phase 2 | Status: UNKNOWN